» Articles » PMID: 32023372

Six-Year Follow-up of a Trial of Antenatal Vitamin D for Asthma Reduction

Abstract

Background: We previously reported the results of a trial of prenatal vitamin D supplementation to prevent asthma and recurrent wheeze in young children, which suggested that supplementation provided a protective effect at the age of 3 years. We followed the children through the age of 6 years to determine the course of asthma and recurrent wheeze.

Methods: In this follow-up study, investigators and participants remained unaware of the treatment assignments through the children's sixth birthday. We aimed to determine whether, when maternal levels of 25-hydroxyvitamin D were taken into account, children born to mothers who had received 4400 IU of vitamin D per day during pregnancy (vitamin D group) would have a lower incidence of asthma and recurrent wheeze at the age of 6 years than would those born to mothers who had received 400 IU of vitamin D per day (control group). Time-to-event methods were used to compare the treatment groups with respect to time to the onset of asthma or recurrent wheeze. Multivariate methods were used to compare longitudinal measures of lung function between the treatment groups.

Results: There was no effect of maternal vitamin D supplementation on asthma and recurrent wheeze in either an intention-to-treat analysis or an analysis with stratification according to the maternal 25-hydroxyvitamin D level during pregnancy. There was no effect of prenatal vitamin D supplementation on most of the prespecified secondary outcomes. We found no effects of prenatal supplementation on spirometric indexes. Although there was a very small effect on airway resistance as measured by impulse oscillometry, this finding was of uncertain significance.

Conclusions: Vitamin D supplementation during the prenatal period alone did not influence the 6-year incidence of asthma and recurrent wheeze among children who were at risk for asthma. (Funded by the National Heart, Lung, and Blood Institute; VDAART ClinicalTrials.gov number, NCT00920621.).

Citing Articles

Specific airway resistance according to early maternal vitamin D status during pregnancy in children aged 5 to 6 years old from the FEPED cohort (RESPIFEPED).

Gonsard A, Marquant F, Elie C, Le Bourgeois M, Houdouin V, Delclaux C Eur J Pediatr. 2025; 184(2):176.

PMID: 39907821 PMC: 11799076. DOI: 10.1007/s00431-024-05954-0.


Pharmacokinetic modeling of prenatal vitamin D exposure and the impact on offspring asthma and pulmonary function.

Shadid I, Brustad N, Chawes B, Moes D, Weiss S, Guchelaar H Biomed Pharmacother. 2025; 183:117859.

PMID: 39874780 PMC: 11866507. DOI: 10.1016/j.biopha.2025.117859.


European Respiratory Society Research Seminar on Preventing Pediatric Asthma.

Grigg J, Barratt B, Bonnelykke K, Custovic A, Ege M, Pasquali C Pediatr Pulmonol. 2024; 60(1):e27401.

PMID: 39625247 PMC: 11748117. DOI: 10.1002/ppul.27401.


Philippine guidelines on the dietary primary prevention of allergic diseases in children.

Casis Hao R, Genuino M, Tan-Lim C, Capulong R, Castor M, Francisco P Asia Pac Allergy. 2024; 14(4):191-213.

PMID: 39624442 PMC: 11608615. DOI: 10.5415/apallergy.0000000000000158.


Integrating Endocrine, Genomic, and Extra-Skeletal Benefits of Vitamin D into National and Regional Clinical Guidelines.

Wimalawansa S, Weiss S, Hollis B Nutrients. 2024; 16(22).

PMID: 39599755 PMC: 11597479. DOI: 10.3390/nu16223969.


References
1.
Oksel C, Granell R, Haider S, Fontanella S, Simpson A, Turner S . Distinguishing Wheezing Phenotypes from Infancy to Adolescence. A Pooled Analysis of Five Birth Cohorts. Ann Am Thorac Soc. 2019; 16(7):868-876. PMC: 6600832. DOI: 10.1513/AnnalsATS.201811-837OC. View

2.
Saadoon A, Ambalavanan N, Zinn K, Ashraf A, MacEwen M, Nicola T . Effect of Prenatal versus Postnatal Vitamin D Deficiency on Pulmonary Structure and Function in Mice. Am J Respir Cell Mol Biol. 2016; 56(3):383-392. PMC: 5359534. DOI: 10.1165/rcmb.2014-0482OC. View

3.
Grebe S, Singh R . LC-MS/MS in the Clinical Laboratory - Where to From Here?. Clin Biochem Rev. 2011; 32(1):5-31. PMC: 3052391. View

4.
Chen L, Zosky G . Lung development. Photochem Photobiol Sci. 2016; 16(3):339-346. DOI: 10.1039/c6pp00278a. View

5.
Hansdottir S, Monick M, Lovan N, Powers L, Gerke A, Hunninghake G . Vitamin D decreases respiratory syncytial virus induction of NF-kappaB-linked chemokines and cytokines in airway epithelium while maintaining the antiviral state. J Immunol. 2009; 184(2):965-74. PMC: 3035054. DOI: 10.4049/jimmunol.0902840. View